
Pegasys Life Sciences Private Limited
About Pegasys Life Sciences Private Limited
Data last updated:
Pegasys Life Sciences Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 August 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2015PTC072637. Its GSTIN is 07AAJCP9906E1Z7 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kripa Gupta Shanker and Rimjhim Rastogi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 437 Gaur Green Avenue Abhaykhand – 2 Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2024, the company reported a revenue of ₹63.48 Lakh, a growth of 45% compared to the previous year. For the same year it recorded a net profit of ₹2.99 Lakh (net margin 4.7%) and EBITDA of ₹4.15 Lakh (EBITDA margin 6.5%). Revenue has grown at a compounded annual rate (CAGR) of 93% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Pegasys Life Sciences Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 437 Gaur Green Avenue Abhaykhand – 2 Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Pegasys Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pegasys Life Sciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Pegasys Life Sciences Private Limited, buy the company report.
Financials of Pegasys Life Sciences Private Limited
FY 2025 filings availablePegasys Life Sciences Private Limited reported revenue of ₹63.48 Lakh (up 45% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 93% over three years, including 45% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.99 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Pegasys Life Sciences Private Limited, buy the company report.
Board of directors of Pegasys Life Sciences Private Limited
Pegasys Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rimjhim Rastogi | Additional Director | 10 Jan 2020 | 6 Years 9 Months | Current |
| Kripa Gupta Shanker Also directs: Think Big E-Ventures Private Limited | Director | 11 Aug 2015 | 11 Years 2 Months | Current |
Shareholding
The shareholding of Pegasys Life Sciences Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Pegasys Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pegasys Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pegasys Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Pegasys Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCP9906E1Z7 | Delhi | Active | 28 May 2019 |
To see the full GST registrations and return filing status of Pegasys Life Sciences Private Limited, buy the company report.
Recent activity
Pegasys Life Sciences Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Aklesh Raj Rastogi ceased to be Additional Director on 13 Jan 2020.
Frequently asked questions
Pegasys Life Sciences is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 August 2015 (11+ years old) and is registered under CIN U24233UP2015PTC072637.
Pegasys Life Sciences has 2 current directors:
- Rimjhim Rastogi - Additional Director
- Kripa Gupta Shanker - Director
The latest financial statements of Pegasys Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Pegasys Life Sciences is 07AAJCP9906E1Z7, registered in Delhi.
The CIN (Corporate Identification Number) of Pegasys Life Sciences is U24233UP2015PTC072637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pegasys Life Sciences was incorporated on 11 August 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
Aklesh Raj Rastogi ceased to be Additional Director on 13 Jan 2020. Rimjhim Rastogi was appointed as Additional Director on 10 Jan 2020. Shobha Data ceased to be Director on 15 May 2019. Pegasys Life Sciences has 4 board changes on record in total.
The registered office of Pegasys Life Sciences is at C – 437 Gaur Green Avenue Abhaykhand – 2 Indirapuram, Ghaziabad, Uttar Pradesh, India – 201010.
Pegasys Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Pegasys Life Sciences is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.

